Quanterix Corp.

Quanterix Corp.

Quanterix Corp.

Overview
Date Founded

2007

Headquarters

113 Hartwell Avenue,Lexington, MA 02421

Type of Company

Public

Employees (Worldwide)

314

Industries

Pharmaceuticals
Market & Policy Research
IT Consulting & Services
Medical Support Services
Biotechnology
Medical Products & Equipment
Retail: Drug Stores

Company Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Contact Data
Trying to get in touch with decision makers at Quanterix Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chairman, Chief Executive Officer, President

Interim Chief Financial Officer

Chief Operating Officer

General Counsel & Secretary

General Counsel

Senior Vice President, Research & Development & Chief Technology Officer

Vice President & General Manager of Applications & Reagents

Senior Director, Engineering

Director of Communications & Marketing

Board of Directors

Chairman, Chief Executive Officer, President at Quanterix Corp.

Founder & Managing Director at ARCH Venture Partners

Co-Founder at Quanterix Corp.

Chief Operations Officer at Sherlock Biosciences, Inc.

Senior Vice President, General Counsel & Corporate Secretary at Itron, Inc.

Co-Founder at Liberty Lane Partners LLC

Founder & Chairman at Novalis LifeSciences

Mentor at Stony Brook University

Vice President-Business Development at bioMerieux, Inc.

Paths to Quanterix Corp.
Potential Connections via
Relationship Science
You
Quanterix Corp.
Owners & Shareholders
Details Hidden

Our firm was founded to help small investors build significant capital over time. Since we believe in owning as many promising stocks as possible, we generally buy on margin.* Borrowing to invest can force liquidations if the market collapses, so we try to balance this exposure by selling short. This ability to seek investments both up and downstream is rarely available to smaller investors. We, however, view it as an effective tool that doubles our clients' dollars at work (it also doubles our commissions), while moderately reducing their exposure to abrupt swings in the market. Our approach is not for the short-term investor. Clients must be able and willing to accept risks. Accounts will experience sharp fluctuations month to month, year to year. It takes a strong stomach to invest with us. Clients entrust decision making for their accounts to us: we buy and sell without asking our clients to authorize in advance each transaction. We are paid commissions for our work

Details Hidden

Frontier manages equity portfolios generally on a fully discretionary basis. They believe that a disciplined and consistent approach to fundamental, bottom-up research leads to superior long-term investment performance. The firm invests in stocks with prospects for improving businesses with long-term unrecognized earnings power that are selling at attractive valuations.

Details Hidden

GIM is an active manager that employs fundamental bottom-up research to invest in stocks of companies that they believe exhibit a critical combination of superior growth prospects and attractive stock valuations. The firm specializes in small/micro-cap equity securities.

Recent Transactions
Details Hidden

Quanterix Corp. issued USD Common Stock

Details Hidden

Quanterix Corp. issued USD Common Stock

Details Hidden

Quanterix Corp. issued . USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Underwriter

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Legal Advisor

Advised onQuanterix Corp. issued USD Common Stock

Managing Director, Health Care Investment Banking Group

Advised onQuanterix Corp. issued USD Common Stock

Clients

DuPont de Nemours, Inc. operates as a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics & Imaging, Nutrition & Biosciences, Transportation & Industrial, Safety & Construction, and Non-Core. The Electronics & Imaging segment provides permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless and electrolytic metallization solutions, as well as patterning solutions and materials and innovative metallization processes for metal finishing, decorative, and industrial applications. The Nutrition & Biosciences segment provides solutions for the global food and beverage, dietary supplements, pharma, home and personal care, energy and animal nutrition markets. The Transportation & Industrial segment engineering resins, adhesives, silicones, lubricants and parts to engineers and designers in the transportation, electronics, healthcare, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The Safety & Construction segment provides engineering products and integrated systems for a number of industries including, worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The Non-Core segment supplier of key materials for the manufacturing of photovoltaic cells and panels, including SOLAMET metallization pastes, TEDLAR backsheet materials, and FORTASUN silicone encapsulants and adhesives. The company was founded in 1897 and is headquartered in Wilmington, DE.

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Key Stats and Financials As of 2020
Market Capitalization
$2.38B
Total Enterprise Value
$1.23B
Earnings Per Share
$-1.07
Net Profit
$-31.5M
EBITDA
$-27M
EBITDAMargin
-31.3%
Total Debt
$30.8M
Total Equity
$206M
Enterprise Value / Sales
14.18x
TEVNet Income
-38.86x
Debt TEV
0.03x
Three Year Compounded Annual Growth Rate Of Revenue
55.72%
Revenue
$86.4M
Investors
Details Hidden

Bain Capital Ventures seeks investment opportunities in companies located in the US. The firm focuses on companies operating in the fields of infrastructure software, SaaS, data services, marketing tech, finTech, consumer and healthcare with an investment size ranging from $1 million to $100 million. It provides financing for seed to growth stage capital requirements.

Details Hidden

In-Q-Tel seeks investment opportunities in the companies located in the US. The fund targets companies operating in the fields of application software & analytics, bio & chemical technologies, communications & infrastructure, digital identity & security and embedded systems & power. Investment size ranging from $0.5 to $3 million. It provides financing for seed, early, late stage capital requirements.

Details Hidden

Former Executive Chairman at True Materials, Inc.

Suppliers
Stratec SE Industrial Machinery & Manufacturing | Birkenfeld, Germany

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.

Tufts University Schools & Student Services

Tufts University is a private research university located in Medford/Somerville, near Boston, in the U.S. state of Massachusetts. The university is organized into ten schools, including two undergraduate programs and eight graduate divisions, on four campuses in Massachusetts and the French Alps. The university emphasizes active citizenship and public service in all of its disciplines and is known for its internationalism and study abroad programs.

Paramit Holding Co. LLC Holding Companies | New York, NY

Paramit Holding Co. LLC operates as a holding company. It offers electro medical products. The company is headquartered in New York, NY.

Competitors
Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Myriad Genetics, Inc. Medical Products & Equipment - Salt Lake City, UT

Our goal, at Myriad, is to make a difference in patient’s lives and for the past twenty years, the Company’s strategy has been guided by this mission. To accomplish this, we are focused on revolutionizing patient care through the development and marketing of transformative tests which address pressing clinical needs across multiple medical specialties. Over the last twenty years, Myriad has invested heavily in the education of patients and health care providers on the role genes and their related proteins play in disease. Almost one million patients have already benefited from Myriad’s informative testing, which helps physicians better manage their health care. Today, Myriad continues to build on this strong tradition. We are working to expand our reach by introducing new genetic tests and molecular diagnostic tests for a number of diseases. We also are focused on extending our mission internationally, in an effort to broaden our geographic footprint and provide critical information to more patients and healthcare providers

Laboratory Corporation of America Holdings Medical Support Services - Burlington, NC

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1995 and is headquartered in Burlington, NC.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Quanterix Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Quanterix Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Quanterix Corp..